ArticleUltrasonography (Seoul, Korea)2019
Non-enhancing gliomas: does intraoperative ultrasonography improve resections?
Article in Ultrasonography (Seoul, Korea), 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers, 2 of them syntheses that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
8 citing papers in PubMed, 2 syntheses or guidelines pooled it.
- A systematic review of the effectiveness and the diagnostic accuracy of intraoperative ultrasound in the resection of low-grade gliomas.Journal of ultrasound · 2025Pooled it
- Reliability of intraoperative ultrasound in detecting tumor residual after brain diffuse glioma surgery: a systematic review and meta-analysis.Neurosurgical review · 2020Pooled it
- Next-generation agents for fluorescence-guided glioblastoma surgery.Bioengineering & translational medicine · 2024Article
- Choice of intraoperative ultrasound adjuncts for brain tumor surgery.BMC medical informatics and decision making · 2022Article
- Advantages of Using 3D Intraoperative Ultrasound and Intraoperative MRI in Glioma Surgery.Frontiers in oncology · 2022Article
- Full-course resection control strategy in glioma surgery using both intraoperative ultrasound and intraoperative MRI.Frontiers in oncology · 2022Article
- Resection and survival data from a clinical trial of glioblastoma multiforme-specific IRDye800-BBN fluorescence-guided surgery.Bioengineering & translational medicine · 2021Article
- Navigated intraoperative ultrasonography for brain tumors: a pictorial essay on the technique, its utility, and its benefits in neuro-oncology.Ultrasonography (Seoul, Korea) · 2020Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
purposeNon-enhancing diffuse gliomas are a challenging surgical proposition. Delineation of tumour extent on preoperative imaging and intraoperative visualization are often difficult.
methodsWe retrospectively analyzed all cases of non-enhancing gliomas that were operated on using navigated 3-dimensional ultrasonography (US). Tumour delineation (good, moderate, or poor) on preoperative magnetic resonance imaging (MRI) and intraoperative US was compared. Post-resection US findings with respect to residual tumour status were compared to the postoperative imaging findings. The extent of resection was calculated and recorded.
resultsThere were 55 gliomas (43 high-grade, 12 low-grade). Forty were close to eloquent areas. The pre-resection concordance of MRI with US was 56%, with US defining more tumours as well-delineated (n=26) than MRI (n=13). US was used for resection control in 50 cases. Gross tumour resection was achieved in 24 cases (51%). US correctly predicted the residual tumour status in 78% of cases. The use of US led to radical resections even in some tumours preoperatively deemed to be unresectable. However, eloquent location was the only independent predictor of the extent of resection.
conclusionIntraoperative US is a useful tool for guiding resection of non-enhancing gliomas. It may be better than MRI for delineating these tumours, and may thereby facilitate improved resection of these otherwise poorly delineated tumours. However, functional boundaries remain the main limiting factor for achieving complete resection of non-enhancing gliomas.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.